Spectral Domain Optical Coherence Tomography Analysis for Glaucoma
Primary Purpose
GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
RS-3000 OCT measurements
Sponsored by

About this trial
This is an interventional screening trial for GLAUCOMA 1, OPEN ANGLE, D (Disorder) focused on measuring Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma
Eligibility Criteria
Inclusion Criteria:
The POAG group inclusion criteria were;
- IOP higher than 21 mmHg before treatment on three different visits,
- Best corrected VA of 20/25 or better with a spherical equivalent within ±5 D and a cylinder correction within +3 D;
- An open angle confirmed by gonioscopy.
- Glaucomatous optic disc damage defined as by the presence of glaucomatous optic neuropathy like rim thinning (diffuse or local), cupping, notching, and a cup/disc ratio >0.2 with asymmetry.
NTG group were included if;
• They had the same optic disc and visual field criteria as for the POAG patients with the exception that their IOP was as ≤21 mmHg on three separate visits without any glaucomatous treatment.
The control group
- Who had no ocular disease
- Who had not undergone ocular surgery or laser procedures.
- With a normal anterior segment, open angles, and normal posterior segment findings also normal optic nerve head appearance in their ophthalmic examination.
- The IOP measurements were lower than 21 mmHg, and full-threshold 30-2 HFA were also within normal limits in the control group.
Exclusion Criteria:
- Subjects with any retinal disease, diabetes mellitus, or neurological disease or who had undergone ocular surgery and laser procedures.
- Subjects with pseudoexfoliation glaucoma and pigmentary glaucoma were excluded.
Sites / Locations
- Inonu University School of Medicine
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Sham Comparator
Active Comparator
Active Comparator
Arm Label
Normal subjects
Primary open angle glaucoma
Normal tension glaucoma
Arm Description
Outcomes
Primary Outcome Measures
Ganglion cell complex, retinal nerve fiber layer and retinal thickness measurements of glaucoma patients using spectral domain OCT.
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01612416
Brief Title
Spectral Domain Optical Coherence Tomography Analysis for Glaucoma
Official Title
Comparison of Ganglion Cell and Retinal Nerve Fiber Layer Thickness in Primary Open Angle Glaucoma and Normal Tension Glaucoma With Spectral Domain OCT
Study Type
Interventional
2. Study Status
Record Verification Date
June 2012
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
June 2011 (Actual)
Study Completion Date
June 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Inonu University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to examine whether there is a difference in macular ganglion cell complex thickness and retinal nerve fiber layer thickness in early-stage Primary open angle glaucoma and normal tension glaucoma with spectral domain OCT.
Detailed Description
Glaucoma is a progressive optic neuropathy characterized by gradual degeneration of neuronal tissue in which retinal ganglion cells (RGCs) are injured, leading to the loss of the visual field.Recent studies have separately demonstrated a reduction in the macular retinal thickness and in the retinal nerve fibers in both POAG and NTG.It has been demonstrated that in early stage NTG macular GCC thickness showed a strong correlation with thickness of the RNFL. However there have yet to be any reports regarding the comparison of macular thickness, ganglion cell complex and retinal nerve fiber layer between POAG and NTG with RS-3000 RetinaScan at early stage.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
GLAUCOMA 1, OPEN ANGLE, D (Disorder)
Keywords
Ganglion Cell complex, Retinal Nerve Fiber Layer,Glaucoma
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
169 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Normal subjects
Arm Type
Sham Comparator
Arm Title
Primary open angle glaucoma
Arm Type
Active Comparator
Arm Title
Normal tension glaucoma
Arm Type
Active Comparator
Intervention Type
Device
Intervention Name(s)
RS-3000 OCT measurements
Other Intervention Name(s)
GCC and RNFL in Open Angle and Normal Tension Glaucoma.
Intervention Description
Ganglion cell, retinal nerve fiber layer and retinal thickness measurements of normal subjects, primary open angle glaucoma and normal tension glaucoma patients using RS-3000 OCT RetinaScan
Primary Outcome Measure Information:
Title
Ganglion cell complex, retinal nerve fiber layer and retinal thickness measurements of glaucoma patients using spectral domain OCT.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
28 Years
Maximum Age & Unit of Time
72 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
The POAG group inclusion criteria were;
IOP higher than 21 mmHg before treatment on three different visits,
Best corrected VA of 20/25 or better with a spherical equivalent within ±5 D and a cylinder correction within +3 D;
An open angle confirmed by gonioscopy.
Glaucomatous optic disc damage defined as by the presence of glaucomatous optic neuropathy like rim thinning (diffuse or local), cupping, notching, and a cup/disc ratio >0.2 with asymmetry.
NTG group were included if;
• They had the same optic disc and visual field criteria as for the POAG patients with the exception that their IOP was as ≤21 mmHg on three separate visits without any glaucomatous treatment.
The control group
Who had no ocular disease
Who had not undergone ocular surgery or laser procedures.
With a normal anterior segment, open angles, and normal posterior segment findings also normal optic nerve head appearance in their ophthalmic examination.
The IOP measurements were lower than 21 mmHg, and full-threshold 30-2 HFA were also within normal limits in the control group.
Exclusion Criteria:
Subjects with any retinal disease, diabetes mellitus, or neurological disease or who had undergone ocular surgery and laser procedures.
Subjects with pseudoexfoliation glaucoma and pigmentary glaucoma were excluded.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Penpe G Firat, M.D.
Organizational Affiliation
Assistant Professor
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Selim Doganay, M.D
Organizational Affiliation
Professor
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Ersan E Demirel, M.D.
Organizational Affiliation
Resident
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Cemil Colka, M.D.
Organizational Affiliation
Associate Professor
Official's Role
Study Chair
Facility Information:
Facility Name
Inonu University School of Medicine
City
Malatya
ZIP/Postal Code
44280
Country
Turkey
12. IPD Sharing Statement
Citations:
PubMed Identifier
17554482
Citation
Ojima T, Tanabe T, Hangai M, Yu S, Morishita S, Yoshimura N. Measurement of retinal nerve fiber layer thickness and macular volume for glaucoma detection using optical coherence tomography. Jpn J Ophthalmol. 2007 May-Jun;51(3):197-203. doi: 10.1007/s10384-006-0433-y. Epub 2007 Jun 7.
Results Reference
background
Learn more about this trial
Spectral Domain Optical Coherence Tomography Analysis for Glaucoma
We'll reach out to this number within 24 hrs